Insider Transactions in Q2 2023 at Acutus Medical, Inc. (AFIB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
James E Flynn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8,400
+28.75%
|
-
|
|
Jun 15
2023
|
Niamh Louise Pellegrini Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.6%
|
-
|
|
Jun 15
2023
|
Jason K Garland Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+27.27%
|
-
|
|
Jun 15
2023
|
Andrew El Bardissi Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.75%
|
-
|
|
Jun 15
2023
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,920
+33.33%
|
-
|
|
Jun 15
2023
|
David P Bonita Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.75%
|
-
|
|
Jun 15
2023
|
John F Sheridan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+25.65%
|
-
|
|
Jun 15
2023
|
Shaden Marzouk Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.75%
|
-
|
|
Jun 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,290
-4.55%
|
$0
$0.85 P/Share
|
|
Apr 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-0.86%
|
$0
$0.75 P/Share
|
|
Apr 01
2023
|
Charlie Piscitello SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-0.99%
|
$0
$0.75 P/Share
|
|
Apr 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,165
-0.83%
|
$0
$0.75 P/Share
|
|
Apr 01
2023
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
321
-0.48%
|
$0
$0.75 P/Share
|